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NAP-22omposed of many molecular species of lipids and proteins. These molecules do
not mix ideally. In the plane of the membrane components are segregated into domains that are enriched in
certain lipids and proteins. Cholesterol is a membrane lipid that is not uniformly distributed in the
membrane. Proteins play an important role in determining cholesterol distribution. Certain types of protein
lipidation are known to cause the lipoprotein to sequester with cholesterol and to stabilize cholesterol-rich
domains. However, proteins that are excluded from such domains also contribute to the redistribution of
cholesterol. One of the motifs that favor interaction with cholesterol is the CRAC motif. The role of the CRAC
motif of the gp41 fusogenic protein of HIV is discussed. The distribution of the multianionic lipid,
phosphatidylinositol(4,5)bis-phosphate (PtnIns(4,5)P2), is also not uniform in cell membranes. This lipid has
several functions in the cell, including a morphological role in determining the sites of attachment of the
actin cytoskeleton to the plasma membrane. PtnIns(4,5)P2 is sequestered by proteins having clusters of
cationic residues in their sequence. Certain proteins containing cationic clusters also contain moieties such as
myristoylation or a CRAC segment that would also endow themwith the ability to sequester to a cholesterol-
rich domain. These proteins interact with PtnIns(4,5)P2 in a cholesterol-dependent manner forming domains
that are enriched in both cholesterol and in PtnIns(4,5)P2 but can also be distinct from liquid-ordered raft-
like domains.
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ll rights reserved.1. General principles
1.1. Chemical composition and organization of biological membranes
Biological membranes are complex mixtures composed primarily
of lipids and proteins. The number of individual molecular species is
quite large. For the lipids of mammalian membranes there are
glycerol-based lipids, sphingolipids and cholesterol. Within each of
the ﬁrst two classes there are many different examples. Furthermore
for each type of lipid, such as phosphatidylcholine or sphingomyelin,
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variation in the length and degree of unsaturation of the hydrocarbon
chains. In addition to the diacylglycerophospholipids, there are lipid
species with long chain alcohols in ether linkage to glycerol as well as
the variation among sphingolipids in having dihydrosphingosine in
place of sphingosine. The speciﬁc lipids in a particular membrane will
depend on the species, tissue and subcellular location fromwhich the
lipid is derived. The sterol in yeast membranes is ergosterol, rather
than cholesterol and plants have sitosterol. Most of the sterol is
present in the plasma membrane and only small amounts in
intracellular membranes. Cardiolipin is a speciﬁc lipid marker for
mitochondrial membranes. Similarly the nature of proteins present in
a membrane will also be dependent on the species and membrane
type. The number of different proteins in a particular membrane is
large. It is estimated that 20–30% of the genome codes for
transmembrane helical integral membrane proteins [1]. In addition
there are also integral membrane proteins that are based on a β-barrel
structure as well as peripheral membrane proteins. Thus, because of
the large number of different molecular species of lipids, as well as the
large number of different membrane proteins, there is great complex-
ity in biological membranes on a molecular level.
In contrast to the large variety of chemical species in a membrane,
the predominant structural basis of membranes is the bilayer. Both
glycerolipids as well as sphingolipids are amphiphilic and most of
them will spontaneously form a bilayer structure. In puriﬁed form,
however, some of the lipids form inverted phases, but large areas of
inverted phase are avoided in biological membranes so as to maintain
a permeability barrier. Despite this simple common structure,
biological membranes are not uniform. They have well documented
transmembrane asymmetry, as well as inhomogenieties in the plane
of the membrane. These lateral inhomogenieties are a result of
preferential interactions of certain molecules. Phospholipid translo-
cases contribute to the asymmetric transmembrane distribution of
lipids, while the asymmetric distribution of proteins is determined by
their vectorial insertion during membrane biogenesis.
There has been extensive work over the years in deﬁning phase
diagrams of lipid mixtures. Gel state immiscibility is common,
however liquid–liquid immiscibility is rarer. An example of a lipid
mixture that shows liquid–liquid immiscibility is one with equimolar
amounts of dioleoylphosphatidylcholine, sphingomyelin and choles-
terol [2]. This lipid mixture has been widely studied by many
techniques for its ability to form two immiscible liquid domains.
One of these domains is enriched in sphingomyelin and cholesterol
and is described as being in a liquid-ordered phase (Lo), in contrast to
the surrounding domain that is in the liquid-disordered phase (Ld).
There has been considerable interest in this phenomenon because it
was believed that the liquid-ordered phase resembled the so-called
“raft” domains of biological membranes. However, it is now
appreciated that raft domains of biological membranes are smaller
and more transient. Rafts in biological membranes are considered to
be in the range of 10 to 100 nm and too small for visualization by light
microscopy. The smaller size of these domains in biological mem-
branes has recently been explained by the presence of integral
membrane proteins attached to the cytoskeleton that act as obstacles
to limit the size of lipid domains in biological membranes [3]. In
addition to lateral domain formation being promoted by interactions
among lipids, proteins can also facilitate domain formation by
preferential interaction with certain lipids. Cholesterol is a major
lipid component of the plasma membrane of mammalian cells. The
chemical structure of cholesterol with its four fused rings and small
hydroxyl headgroup is quite different from that of polar lipids with
ﬂexible hydrocarbon chains and a large polar headgroups. It thus
would be expected a priori that proteins would not interact to the
same extent with both phospholipids and cholesterol. Such prefer-
ential interaction is sufﬁcient to promote lateral phase separation of
the lipid components.1.2. Domains by attraction or exclusion
The formation of a domain induced by a protein interacting with
particular lipids is one mechanism for this segregation to occur.
However, thermodynamically it is required that a protein that avoids
interaction with particular lipids will also cause the formation of
domains that are enriched in those lipids. The formation of
cholesterol-rich domains will be used as an example. If a protein
interacts with cholesterol more than with other membrane compo-
nents, it will promote the formation of a cholesterol-rich domain. This
is a direct mechanism for protein-induced domain formation.
However, it is also the case that a protein excluded from a
cholesterol-rich region of the membrane, will also promote the
formation of a cholesterol-rich domain. This would be expected to be a
fairly common situation since cholesterol causes the tighter packing of
lipid in the liquid-crystalline state and inhibits the insertion of other
molecules. The protein will then stabilize the cholesterol-depleted
region of the membrane, forcing the cholesterol to concentrate in
other regions that then become enriched in cholesterol. Experimental
evidence for this type of phenomenon has been presented [4].
2. Cholesterol-rich domains
2.1. Size of domains
Raft domains inbiologicalmembranesvarygreatly in size and lifetime
but in general these domains in biological membranes are smaller and
shorter lived than those formed by simple lipid mixtures [5]. However,
there are some cases of larger size raft-like domains in biological
membranes such as caveolae that can form micron size domains [6]. In
addition, it has been demonstrated that giant plasmamembrane vesicles
or blebs formed from the plasma membranes of cultured mammalian
cells can also contain large domains with ﬂuid–ﬂuid immiscibility [7].
However, phase segregation into optically resolvable domains occurs
only at temperatures below 25 °C. At 37 °C, the membranes of these
vesicles are almost completely optically homogenous.
2.2. Proteins that incorporate into cholesterol-rich domains
It was indicated above that proteins are often excluded from
cholesterol-rich domains because the cholesterol induces tighter
packing of the bilayer. Nevertheless, certain proteins are found to
preferentially partition into such domains. Our understanding of the
molecular basis for the partitioning of proteins between raft and non-
raft domains is incomplete. There are also methodological difﬁculties
in separating raft and non-raft domains in order to do a proteomics
analysis of the constituents of each fraction [8]. There are other
complications such as the apparent heterogeneity of membrane rafts
as well as the fact that some proteins are well integrated into rafts,
while others only associate transiently. Nevertheless, there are some
generalizations that can be made regarding the factors that favor the
partitioning of proteins into rafts.
2.2.1. Lipidation
Four types of lipidation are found in proteins that associate with
raft domains. These are acylation with either myristic acid on the N-
terminal amino group or palmitic acid on cysteine residues [9–12],
GPI-linkage [13–17] and the covalent attachment of cholesterol [18]. It
would be expected that saturated acyl chains and cholesterol moieties
that are attached to proteins would partition into raft domains
because of their smooth, regular surface. Free cholesterol itself is of
course a component of rafts. In addition, lipids with saturated acyl
chains are more readily accommodated into raft domains than are
lipids with unsaturated acyl chains. In particular, lipids with
polyunsaturated acyl groups are excluded from raft domains [19].
The structure of the GPI-linkage is that it has a phosphatidylinositol
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headgroup. The most abundant form of PtnIns in mammalian
membranes is 18:0/20:4. The arachidonoyl chain at the sn-2 position
of glycerol would inhibit partitioning into a raft domain. However, it
has recently been found that there is remodeling of the acyl chains of
PtnIns when it is converted to the ﬁnal GPI anchor that is then linked
with proteins [20,21]. In its ﬁnal form of the GPI anchor the
arachidonoyl (20:4) chain of PtnIns is replaced by a stearoyl (18:0)
group that would be expected to partitionwell into raft domains. Thus
the acyl chain composition of the GPI anchor is uncommon in having a
saturated acyl chain at the sn-2 position. It is thus likely that this acyl
chain replacement has some functional signiﬁcance.
2.2.2. Protein segments
Less is known about how peptide segments of proteins affect the
partitioning of the protein between raft and non-raft domains. Some
proteins are known to sequester to raft domains [8]. Apart from
lipidated proteins discussed above, one can suggest threemechanisms
by which proteins will preferentially be concentrated in cholesterol-
rich domains. One mechanism is indirect and is a consequence of
interaction of the protein with another protein that is a so-called
scaffolding protein that itself is in a particular domain. Examples of
scaffolding proteins are caveolin [22], present as major components of
caveolae, and ﬂotillin [23] a protein present in the raft domain of many
cells. The question then becomes why a particular scaffolding protein
sequesters into a certain domain. A second mechanism is through the
nature of the topology of the inserted hydrophobic segment of the
protein. It is indicated above that polyunsaturated acyl chainswould be
excluded from rafts, so too would helices that do not have a smooth
contour. This would be analogous to prenylated proteins that have
methyl groups protruding from the hydrocarbon chain and are also
excluded from rafts. One example of a hydrophobic peptide segment
that has recently been shown to preferentially interact with choles-
terol is the hydrophobic segment of the epsilon isoform of diacylgly-
cerol kinase [24]. The partitioning of integral membrane proteins into
raft domains is discussed inmore detail in the chapter by Gonzalez-Ros
et al. 2008 [25]. The third mechanism is by preferential interaction of
segments of the protein positioned at the membrane interface with
certain lipid components. This mechanism is currently only partly
understood. A developing hypothesis regarding the requirements for
cholesterol recognition at the membrane interface is by interaction of
the sterol with CRAC domains, described below.
2.2.3. CRAC domains
There are also segments of integral membrane proteins that are
located at the membrane interface and are thought to facilitate
interaction with cholesterol. The membrane interface is the barrier
between the membrane and water. It is a complex region with
molecules of both lipid headgroups as well as water. The hydroxyl
group of cholesterol forms part of the membrane interface and is
different in size and hydrophobicity from other major lipid compo-
nents and hence proteins may preferentially interact with the
membrane at sites of cholesterol. The requirements for a protein
segment at the membrane interface to recognize cholesterol is poorly
understood. An evaluation of the common elements present in several
proteins known to interact with cholesterol or that partitioned into
cholesterol-rich domains has led to the development of the CRAC
motif. A CRAC motif is deﬁned as a sequence pattern -L/V-(X)(1–5)-Y-
(X)(1–5)-R/K-, in which (-X-)(1–5) represents between one and ﬁve
residues of any amino acid [26]. The loose requirements for a CRAC
domain predicts that a large number of sequences would favor
interaction with cholesterol [27]. However, if in addition to fulﬁlling
the requirements for a CRAC motif, this segment also is located
adjacent to a transmembrane helix, requiring that it be positioned at
the membrane interface, and furthermore is a segment of a protein
that is known from other criteria to be in a raft domain, then it is morelikely that such a CRAC sequence has a role in sequestering the protein
to a cholesterol-rich membrane domain. The two scaffolding proteins
mentioned above, i.e. ﬂotillin and caveolin, have CRAC domains. Both
ﬂotillin 1 and 2 from humans have 4 predicted CRAC domains, but no
transmembrane helix. Caveolins have a single transmembrane helix.
In the cases of the two more widely expressed forms of caveolin, i.e.
caveolins 1 and 2, the putative transmembrane helix comprises
residues 104–124 and 86–106, respectively. On the amino terminal
side of this putative transmembrane segment there is a CRAC domain
at residues 93–100 for caveolin-1 and at 75–85 for caveolin-2.
However, in the case of caveolin-3 there is no CRAC domain adjacent
to the hydrophobic segment. It is known that caveolin-3 is
palmitoylated [28,29] and this may be the factor that promotes
partitioning to cholesterol-rich domains. In the case of caveolins it has
been found that palmitoylation of the protein is not required for
partitioning into caveolae [30,31], suggesting that the presence of
CRAC domains are responsible for this localization.
One of the ﬁrst proteins studied with a CRAC motif was the
peripheral-type benzodiazepine receptor [26]. The CRAC segment of the
peripheral-type benzodiazepine receptor is also present at the end of a
transmembrane helix near the membrane interface. There is evidence
that this protein facilitates cholesterol import into themitochondria. The
peripheral-type benzodiazepine receptor can be photolabeled with a
sterol and this labeling is prevented by competition with cholesterol
[32]. A model peptide containing this CRAC sequence is also labeled by
the sterol photolabel and this peptide also inhibits cholesterol uptake
[32]. Mutation of the CRAC segment of the peripheral-type benzodia-
zepine receptor results in the loss of cholesterol uptake [33]. In addition,
an NMR study has shown that a peptide comprising this CRAC segment
can form a speciﬁc complex with cholesterol [33].
Another exampleof a CRAC segment thathas received recent interest
is a region in the gp41 fusogenic protein of HIV. This protein has a single
transmembrane helical segment. Adjacent to this helix on the amino
terminal side, is a segment that is rich in Trp residues that endswith the
segment LWYIK. This pentapeptide corresponds to a CRAC domain. It
has been shown that when this sequence is added to a maltose binding
protein the construct has the ability to bind to cholesteryl-hemisucci-
nate agarose [34]. In addition, the blocked peptide N-acetyl-LWYIK-
amide is capable of redistributing cholesterol in mixtures of the sterol
with 1-stearoyl-2-oleoyl phosphatidylcholine [35]. We also demon-
strated using magic angle spinning NMR that this peptide inserts more
deeply into bilayers containing cholesterol than those devoid of
cholesterol. The accuracy of the CRAC algorithm in predicting which
sequences will interact with cholesterol was studied. Interestingly the
sequence IWYIK that is closely related structurally to LWYIK but is not a
CRACmotif, exhibits almost no preferential interactionwith cholesterol
[36]. The ﬁrst residue of this segmentwas systematically changed to the
other hydrophobic residues Ala or Val [37]. Both AWYIK and VWYIK
were weakly active in sequestering cholesterol, somewhat better than
IWYIK but much weaker than LWYIK. These results show some of the
limitations of the CRAC algorithm. The requirements for the CRAC
domainpredict thatVWYIKwouldbeasactive as LWYIKandmuchmore
active than AWYIK. This is not observed. It is therefore likely that there
are some sequence-speciﬁc properties that determine the extent of
preferential interaction with cholesterol.
However, what is particularly striking is that introducing these
same amino acid substitutions by mutation into the intact gp41
protein of HIV results in changes in the ability of the protein to
promote membrane fusion between cells that qualitatively parallel
the observations madewith the peptides interacting with cholesterol-
containing lipid mixtures. The L679I mutation of gp41 has only 42% of
the fusogenic activity of the native protein by the criterion of the
number of nuclei per syncytia [36]. This is slightly lower than the
number of nuclei per syncytia foundwith the L679A or L679Vmutants
which is about 47% [37]. There are of course other factors besides
interaction with cholesterol that determine the fusogenicity of these
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the protein sequence affects both cholesterol afﬁnity of the isolated
segments as well as fusogenicity of the intact protein suggests that
cholesterol interaction with the CRAC segment of gp41 contributes to
the biological properties of the intact protein.
3. Anionic lipid-rich domains
Several proteins involved in signal transduction pathways contain
clusters of cationic amino acid residues in their primary structure.
Such a concentration of positive charge has been shown to promote
the sequestering of anionic lipids into domains. This phenomenon
occurs with many anionic lipids. However, in this reviewwewill focus
on the anionic lipid, phosphatidylinositol-4,5-bis-phosphate (PtnIns
(4,5)P2) [38–40]. This example has been chosen both because domains
of this lipid may have particular biological functions. In addition we
can demonstrate an inter-relationship between formation of domains
of PtnIns(4,5)P2 and the location of cholesterol, thus relating the
formation of anionic lipid clusters with the earlier sections of this
review.
3.1. PtnIns(4,5)P2
PtnIns(4,5)P2 plays a number of import roles in signal transduction.
It is the preferred substrate for certain isoforms of phospholipase C
that cleaves the lipid into two secondary messengers, the lipid
messenger diacyl glycerol and water-soluble inositol triphosphate
[41]. In addition, PtnIns(4,5)P2 has a high afﬁnity for binding to
pleckstrin homology (PH) domains in a number of proteins. There is
also a large and growing list of ion channels and transporters that
exhibit some sensitivity for PtnIns(4,5)P2 [42]. PtnIns(4,5)P2 has a
charge of approximately −4 at neutral pH. It is thus more prone to
recruitment into domains by proteins with cationic clusters, largely
through electrostatic interactions [40].
The majority of PtnIns(4,5)P2 in the cell is in the plasmamembrane
and accounts for approximately 1% of the membrane lipid. It appears
to have an important role in the spatial organization in the cell and is
involved in stabilizing interactions between the actin cytoskeleton
and the plasma membrane [43–47]. Enzymes involved in PtnIns(4,5)
P2 biosynthesis are enriched at sites of actin polymerization [45,48,49]
suggesting that they may play a role in the interactions between the
cytoskeleton and the plasma membrane. However, no mechanism has
been elucidated to explain the sequestration of PtnIns(4,5)P2 to these
sites once it has been produced [50].
There has also been interest in the relationship of PtnIns(4,5)P2
localization and raft domains [51]. It has been shown that PtnIns(4,5)
P2 does not spontaneously cluster in ﬂuid bilayers of phosphatidylcho-
line [52]. In mammalian membranes the most prevalent form of
PtnIns(4,5)P2 is 1-stearoyl-2-arachidonoyl-phosphatidylinositol(4,5)
bis-phosphate. It is known that polyunsaturated acyl chains, like the
arachidonoyl moiety, disfavor partitioning into raft domains [19]. This
is in agreement with the fact that sphingomyelin, a well known raft
component, is not colocalized with PtnIns(4,5)P2 [53]. In addition,
atomic force microscopy studies indicate that in bilayers composed of
both liquid-ordered and liquid-disordered domains, the PtnIns(4,5)P2
sequesters into the disordered domain [54]. It is still possible that
some PtnIns(4,5)P2 is localized in raft domains in cells because it binds
to proteins that are resident in rafts. There may also be more than one
type of PtnIns(4,5)P2 domain in biological membranes and addition-
ally, that the state of PtnIns(4,5)P2 in a membrane is cell type
dependent. This is suggested by the observations that the lateral
mobility of PtnIns(4,5)P2 is found to be different in different cell types.
The mobility is low in atrial myocytes [55] but higher in HEK293 cells
[56,57] or in ﬁbroblasts [58].
We suggest, based on our observations in model systems, that
some proteins can recruit PtnIns(4,5)P2 into cholesterol-rich domainsthat are different from the sphingomyelin-rich, liquid-ordered “raft”
domains that have been sowell characterized in simple lipidmixtures.
One such protein is NAP-22, a 22 kDa mammalian protein (the
equivalent protein found in chickens is CAP-23) that is highly
expressed in neuronal tissue during development and plays an
important role in axonal sprouting and elongation [59]. NAP-22 is
an acidic protein with a pI of 4.6 and is devoid of stretches of
hydrophobic amino acids. The only portion of the protein likely to
partition into a membrane bilayer is the N-terminal myristoyl group,
added by post-translationalmodiﬁcation. Themyristoyl group, being a
saturated acyl chain, is one of the lipidations that augment the
partitioning into raft domains. NAP-22 has been found to bind only to
membranes with sufﬁcient cholesterol [60,61]. The protein also
sequesters to raft-like liquid-ordered domains in model membranes
[62].
A myristoylated, N-terminal fragment of NAP-22 corresponding to
the structuremyristoyl-GGKLSKKKKGYNVNDEKAK-amidewas studied
in simple lipidmixtures of phosphatidylcholine and cholesterol aswell
as after addition of PtnIns(4,5)P2 to the lipids. Amino terminal
fragments of NAP-22 are found abundantly in vivo [63]. This
lipopeptide causes Bodipy-labeled PtnIns(4,5)P2 to be sequestered
into domains in a cholesterol-dependent manner as shown by Bodipy
quenching [64]. In the absence of cholesterol the lipopeptide causes
little clustering of PtnIns(4,5)P2. Furthermore, when the Tyr residue at
position 11 is replaced with Leu, the ability of the lipopeptide to form
domains enriched in PtnIns(4,5)P2 becomes independent of added
cholesterol [64]. There have been suggestions that the ﬂat ring of the
phenolic side-chain of Tyr can stackwith one of the rings of cholesterol.
It should be mentioned that one of the required residues of CRAC
domains is Tyr. DSC results also indicate that this lipopeptide can
redistribute cholesterol in membranes forming cholesterol-rich and
cholesterol-poor domains [64]. Thus, the cluster of cationic residues in
this lipopeptide can induce the segregation of PtnIns(4,5)P2 but the
unusual characteristic of this process is that it is cholesterol-dependent
because of the presence of the myristoyl group and likely also the Tyr
that favor interaction with cholesterol. MAS/NMR showed that
cholesterol affected the nature of the incorporation of this lipopeptide
into bilayers [64]. The cholesterol dependence of this domain
formation was also shown directly using a combination of AFM and
TIRF microscopy [65]. Recently a similar system, corresponding to the
palmitoylated region of GAP-43 together with its cationic cluster, was
shown to sequester PtnIns(4,5)P2 into cholesterol-rich domains [66]. It
has been suggested that there is a relationship between the modes of
action of NAP-22 and of GAP-43 as a result of the common nature of
their interaction with PtnIns(4,5)P2 in cholesterol-rich domains [67].
MARCKS has in common with NAP-22 and GAP-43 the fact that all
three proteins are found in plasmalemmal rafts, and they all regulate
cell cortex actin dynamics [68]. Not surprisingly a model peptide
containing the cationic cluster, but devoid of any cholesterol-binding
myristoyl group or CRAC segment did not show any sensitivity to the
presence of cholesterol in its recruitment of PtnIns(4,5)P2 [38]. Even
the intact MARCKS protein might not exhibit cholesterol-promoted
sequestering of PtnIns(4,5)P2 since the N-terminal myristoyl group is
at residue one, while the cationic cluster is much further toward the
carboxyl terminus at residues 151–175.
The sequestering of PtnIns(4,5)P2 by the myristoylated N-terminal
segment of NAP-22 was also studied in a lipid mixture of sphingo-
myelin, phosphatidylcholine and cholesterol that exhibits the forma-
tion of raft-like domains with the lipid alone. Addition of the
lipopeptide to this mixture caused the recruitment of cholesterol
from the liquid-ordered domains into the liquid-disordered region to
be colocalized with PtnIns(4,5)P2 [54]. As a result the liquid-
disordered domain became more ordered. Thus lipopeptide-induced
domains are formed that are enriched in cholesterol and PtnIns(4,5)P2
but are distinct from the sphingomyelin-rich domains of systems
exhibiting liquid–liquid immiscibility.
Fig. 1. Quenching of the ﬂuorescence emission by N-acetyl-LLVYKDKLRINR-amide
(Ypep) or by N-acetyl-LLVIKDKLRINR-amide (Ipep) of Bodipy TMR-PtdIns(4,5)P2. LUVs
composed of SOPC or SOPC with 40 mol% cholesterol, as indicated. Maximum emission
intensity at 572 or 570 nm is plotted against the peptide concentration. LUVs (100 nm
diameter) were present in the cuvette at a concentration of 50 μM and the Bodipy-
labeled PtdIns (4,5) P2 (GloPIPs Bodipy TMR-PtdIns(4,5)P2-C16, Echelon Biosciences
Inc. (Salt Lake City, UT)) were present as 1.0 mol % of the total lipid.
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protein. This protein is a major component of the erythrocyte
membrane that has an important role in modulating cell morphology
and membrane mechanical properties [69]. It does so by interacting
with both cytoskeletal proteins such as spectrin and actin, as well as
integral membrane proteins such as band 3 and glycophorin. Genetic
defects affecting Band 4.1 result in abnormally shaped erythrocytes
with decreased mechanical stability [70]. There are also a number of
proteins related to Band 4.1 that are found in nucleated cells [71,72]. It
has recently been shown that the N-terminal region of the Band 4.1
protein binds to PtnIns(4,5)P2 resulting in changes in the interactions
of Band 4.1 with other proteins [73]. This process will affect
cytoskeletal arrangements through the interaction of Band 4.1 with
PtnIns(4,5)P2. As with NAP-22, the interaction of Band 4.1 with PtnIns
(4,5)P2 has been suggested to be a consequence of electrostatic
interactions with a cluster of cationic residues on the protein [73].
Charged peripheral membrane proteins can induce domain formation
of anionic lipids [74].
Band 4.1 has a segment comprising residues 211–222 with the
sequence LLVYKDKLRINR. This segment of 12 residues has 4 cationic
amino acids. In addition, it fulﬁlls the requirements of a CRAC motif
[26], having a Tyr residue and in this case, a Leu separated by one
amino acid on the amino terminal side and by a basic residue
separated by two residues on the carboxyl side of the Tyr. Thus, like
the NAP-22 lipopeptide, it could interact with both cholesterol and
with PtnIns(4,5)P2. NAP-22 has a cationic cluster of residues that can
interact with PtnIns(4,5)P2 that is close to the myristoyl group that
would favor interaction with cholesterol. The Band 4.1 segment also
has a cationic cluster that in this case is together with a cholesterol-
interacting CRAC domain. Another protein segment that has both a
cholesterol-seeking CRAC domain in the same protein segment that
has a cationic cluster to recruit PtnIns(4,5)P2 is present in the
scaffolding region of caveolin. A peptide corresponding to this region
promotes the sequestrating of both PtnIns(4,5)P2 and cholesterol [75].
In the case of the 12 residue segment from Band 4.1, the sequence is
invariant among members of the family of 4.1 proteins, suggesting its
functional importance. The cholesterol dependence of sequestering
PtnIns(4,5)P2 by an N-acetyl-peptide-amide of this segment of Band
4.1 was compared with a peptide in which the Tyr was substituted
with Ile, thus destroying the CRAC motif that is responsible for its
interaction with cholesterol.
The native sequence for the segment of Band 4.1 from residue 211–
222, N-acetyl-LLVYKDKLRINR-amide, is more efﬁcient in quenching
the ﬂuorescence of Bodipy-PtdIns(4,5)P2 than is the modiﬁed
sequence: N-acetyl-LLVIKDKLRINR-amide in which the Y residue is
replaced by I to destroy the CRAC domain (Fig. 1).
When electrostatic interactions predominate, there is sequestering
of PtdIns(4,5)P2, independent of the nature of the surrounding lipid.
This is the case with the MARCKS peptide that has 13 positive charges
compared to an overall charge of the peptides used in this study of
only +3. As a consequence, electrostatic interactions alone will
provide a stronger driving force for the MARCKS peptide to sequester
PtdIns(4,5)P2 [38]. Another peptide with an intermediate number of 7
positive charges is the amino terminal segment of the protein NAP-22.
This peptide is relatively hydrophilic and has only one aromatic
residue, a Tyr, that can insert into the membrane compared with the
MARCKS peptide that has 5 Phe residues. The NAP-22 peptide has
strong membrane afﬁnity because it is myristoylated at the amino
terminus. N-terminal myristoyl groups are known to facilitate the
targeting of proteins to cholesterol-rich domains in membranes
[76,77]. Regarding the segment of Band 4.1 studied in this work, the
amino terminal tetrapeptide is quite hydrophobic with the sequence
LLVY or LLVI for the two peptides and would facilitate sequestering
the peptide to a membrane. In the former case, for the natural
sequence, LLVY forms part of a CRAC sequence that would favor
binding of the peptide to cholesterol-rich domains. Interestingly, thepeptide N-acetyl-LLVYKDKLRINR-amide sequesters PtnIns(4,5)P2 in a
cholesterol-dependent manner (Fig. 1). This is a consequence of
having a segment that interacts with cholesterol as well as several
cationic amino acids. This is similar to the case of the NAP-22 peptide
that has a cholesterol-targetingmyristoyl group alongwith a cluster of
cationic residues and also sequesters PtnIns(4,5)P2 in a cholesterol-
dependent manner [64,65]. Thus, proteins with cationic clusters will
tend to sequester PtnIns(4,5)P2 as a consequence of electrostatic
interactions. In addition, in cases such as NAP-22 or Band 4.1 this type
of domain formation is dependent on the presence of cholesterol,
while for other proteins such as MARCKS it is not. The fact that
protein-induced sequestration of PtnIns(4,5)P2 can be cholesterol-
dependent does not necessarily imply their recruitment to “raft”
domains in biological membranes. Indeed, studies with the NAP-22
peptide using a combination of AFM and ﬂuorescence microscopy
indicated that both PtnIns(4,5)P2 and cholesterol were sequestered
into the liquid-disordered domain [54], thus being located outside of
the liquid-ordered domain of a raft. There are several types of
cholesterol-rich domains in biological membranes. It is even possible
that not all of them are in the liquid-ordered state. The importance of
cholesterol in the case of Band 4.1 is that it allows a segment of the
protein to recruit PtnIns(4,5)P2 into a domain. Since cytoskeletal
proteins also bind to PtnIns(4,5)P2, this process will also result in the
rearrangement of the cytoskeleton.
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